Literature DB >> 6951665

Antibody-dependent cellular cytotoxicity of leukaemic blast cells and neutrophils from patients with acute myelogenous leukaemia.

F Dallegri, G Holm, G Gahrton.   

Abstract

The antibody-dependent cellular cytotoxicity against ox erythrocytes by blast cells and neutrophils from six patients with acute myelogenous leukaemia and one patient with blast crisis of chronic myelogenous leukaemia was studied. Leukaemic myeloblastic and monocytic cells behaved like potent killer cells toward ox erythrocytes and their activity was comparable with that of neutrophils from leukaemic and normal subjects. The target cell destruction was positively related to the effector cell: target cell ratio and was clearly antibody-dependent since the cytotoxic effect did not involve antibody-unsensitized erythrocytes. We suggest that this experimental system, which involves the use of ox erythrocytes sensitized by purified rabbit anti-ox IgG, provides a new and sensitive method for studying antibody-dependent cellular cytotoxicity by myeloid cells.

Entities:  

Mesh:

Year:  1982        PMID: 6951665      PMCID: PMC1536539     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  7 in total

1.  Polymorphonuclear function in acute myeloblastic leukemia.

Authors:  B Coiffier; Y Frobert; L Revol
Journal:  Biomedicine       Date:  1977-04

2.  Lysis of antibody-treated human erythrocytes by human leukocytes and macrophages in tissue culture.

Authors:  G Holm
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

3.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

4.  Studies in acute leukemia. I. Antibody-dependent and spontaneous cellular cytotoxicity by leukemic blasts from patients with acute nonlymphoid leukemia.

Authors:  G Fernandes; T Garrett; M Nair; D Straus; R A Good; S Gupta
Journal:  Blood       Date:  1979-09       Impact factor: 22.113

5.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

6.  Granulocyte function in untreated acute and chronic granulocytic leukemia.

Authors:  P H Pinkerton; J B Robinson
Journal:  Acta Haematol       Date:  1976       Impact factor: 2.195

7.  Antibody-dependent haemolytic activity of human leukaemic cells.

Authors:  G Holm; M Björkholm; B Böttiger; H Mellstedt; D Pettersson; C Simonsson-Lindemalm
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

  7 in total
  6 in total

1.  Expression of cytolytic functions in HL-60 leukaemic cells after induction of polymorphonuclear leukocyte differentiation.

Authors:  F Dallegri; A Ballestrero; G Frumento; F Patrone
Journal:  Blut       Date:  1986-04

2.  Chemotactic peptide enhancement of PMA triggered monocyte cytotoxicity.

Authors:  F Dallegri; F Patrone; A Ballestrero; G Frumento; C Sacchetti
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

3.  Target cell lysis mediated by concanavalin A-triggered human neutrophils.

Authors:  F Dallegri; F Patrone; A M Maggi; G Frumento; C Sacchetti
Journal:  Blut       Date:  1984-03

4.  Mechanisms of tumour cell destruction by PMA-activated human neutrophils.

Authors:  F Dallegri; G Frumento; F Patrone
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

5.  Neutrophil-mediated cellular cytotoxicity triggered by immobilized aggregated IgG: an in vitro model of cell injury during immune complex diseases.

Authors:  F Dallegri; F Patrone; G Frumento; A Ballestrero; C Sacchetti
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

6.  Neutrophil-mediated antibody-dependent cellular cytotoxicity against erythrocytes. Mechanisms of target cell destruction.

Authors:  F Dallegri; F Patrone; G Holm; G Gahrton; C Sacchetti
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.